(Q44816549)

6 December 2017

Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma (English)

1 reference

6 December 2017

0 references

Gulley ML

1

1 reference

6 December 2017

Burton MP

2

1 reference

6 December 2017

Allred DC

3

1 reference

6 December 2017

Nicholls JM

4

1 reference

6 December 2017

Amin MB

5

1 reference

6 December 2017

Ro JY

6

1 reference

6 December 2017

Schneider BG

7

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 March 1998

1 reference

6 December 2017

1 reference

6 December 2017

29

1 reference

6 December 2017

3

1 reference

6 December 2017

252-259

1 reference

Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Epstein-Barr virus is detected in undifferentiated nasopharyngeal carcinoma but not in lymphoepithelioma-like carcinoma of the urinary bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

The clonal progression in the neoplastic process of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Assessment of p53 expression in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern Asia

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Detection of mutations in the p53 gene in human head and neck carcinomas by single strand conformation polymorphism analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

In-situ carcinoma adjacent to recurrent nasopharyngeal carcinoma. Evidence of a new growth?

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Epstein-Barr-encoded RNA in situ hybridization: diagnostic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

p53 is overexpressed in fifty percent of pre-invasive lesions of head and neck epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 transactivator protein ZEBRA in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Epstein-Barr virus infection and replication in a human epithelial cell system

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

The bZIP transactivator of Epstein-Barr virus, BZLF1, functionally and physically interacts with the p65 subunit of NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Nasopharyngeal carcinoma in situ in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity

1 reference

https://api.crossref.org/works/10.1016%2FS0046-8177%2898%2990044-2

7 January 2021

10.1016/S0046-8177(98)90044-2

Identifiers

DOI

1 reference

6 December 2017

1 reference